Use of Dexmedetomidine in Light to Moderate Sedation in the Patient in the Palliative Situation of a Sars-cov-2 / COVID-19 Infection

NCT04350086 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped unfavorable opinion of the ethics committee

Conditions

COVID-19 Infection
Sars-cov-2
Respiratory Failure
Palliative Situation

Interventions

DRUG: Treatment with Dexmedetomidine

Sponsor

University Hospital, Limoges